130 related articles for article (PubMed ID: 6451698)
1. Purple toe syndrome.
Akle CA; Joiner CL
J R Soc Med; 1981 Mar; 74(3):219. PubMed ID: 6451698
[No Abstract] [Full Text] [Related]
2. "Purple toes" syndrome.
Lebsack CS; Weibert RT
Postgrad Med; 1982 May; 71(5):81-4. PubMed ID: 7071041
[TBL] [Abstract][Full Text] [Related]
3. Purple toes syndrome associated with warfarin therapy in a patient with antiphospholipid syndrome.
Talmadge DB; Spyropoulos AC
Pharmacotherapy; 2003 May; 23(5):674-7. PubMed ID: 12741443
[TBL] [Abstract][Full Text] [Related]
4. Pyogenic granuloma-like lesions during capecitabine therapy.
Piguet V; Borradori L
Br J Dermatol; 2002 Dec; 147(6):1270-2. PubMed ID: 12452889
[No Abstract] [Full Text] [Related]
5. [Purple-toe syndrome - a side effect of peroral anticoagulant therapy].
Rosling H
Lakartidningen; 1983 Nov; 80(48):4700. PubMed ID: 6664170
[No Abstract] [Full Text] [Related]
6. Sunitinib-induced hand-foot syndrome: a new, distinct form.
Fife DJ; Wu JJ; Behnam SE; Linden KG
Clin Exp Dermatol; 2010 Mar; 35(2):200-1. PubMed ID: 19486049
[No Abstract] [Full Text] [Related]
7. Diagnosis in oncology. Hand-foot syndrome.
Jucgla A; Sais G
J Clin Oncol; 1997 Sep; 15(9):3164. PubMed ID: 9312563
[No Abstract] [Full Text] [Related]
8. Clinical pearls: Cold feet.
Legome E
Acad Emerg Med; 2001 Oct; 8(10):998, 1007-9. PubMed ID: 11581088
[No Abstract] [Full Text] [Related]
9. [Blisters unlike others].
Gugerli O; Leupin N
Rev Med Suisse; 2006 Apr; 2(62):1076-7. PubMed ID: 16711153
[No Abstract] [Full Text] [Related]
10. Lichenoid eruption induced by sotalol.
O'Brien TJ; Lyall IG; Reid SS
Australas J Dermatol; 1994; 35(2):93-4. PubMed ID: 7702497
[No Abstract] [Full Text] [Related]
11. Cancer chemotherapy and skin changes.
Vogelzang NJ; Ratain MJ
Ann Intern Med; 1985 Aug; 103(2):303-4. PubMed ID: 3160276
[No Abstract] [Full Text] [Related]
12. Hand-foot syndrome.
Pike K
Oncol Nurs Forum; 2001; 28(10):1519-20. PubMed ID: 11759299
[No Abstract] [Full Text] [Related]
13. Herceptin-taxol related hand and foot syndrome.
Merimsky O; Inbar MJ
Isr Med Assoc J; 2000 Oct; 2(10):786. PubMed ID: 11344738
[No Abstract] [Full Text] [Related]
14. Anthracycline-induced toxicity affecting palmar and plantar skin.
Jones AP; Crawford SM
Br J Cancer; 1989 May; 59(5):814. PubMed ID: 2525400
[No Abstract] [Full Text] [Related]
15. [Dermatologic toxicity to sorafenib].
Velázquez D; de la Cueva P; Zamberk P; Lázaro P
Actas Dermosifiliogr; 2009; 100(6):518-20. PubMed ID: 19709563
[No Abstract] [Full Text] [Related]
16. Allergic contact sensitivity to chlorphenesin.
Burns DA
Contact Dermatitis; 1986 Apr; 14(4):246. PubMed ID: 2941223
[No Abstract] [Full Text] [Related]
17. Images in clinical medicine. Chemotherapy-induced acral erythema.
Pirisi M; Soardo G
N Engl J Med; 1994 May; 330(18):1279. PubMed ID: 8145783
[No Abstract] [Full Text] [Related]
18. [Palmoplantar cutaneous reaction to sorafenib].
Echeverría B; Llombart B; Botella-Estrada R; Guillén C
Actas Dermosifiliogr; 2009 Oct; 100(8):736-7. PubMed ID: 19775561
[No Abstract] [Full Text] [Related]
19. Erythematous eruption of the palms and soles associated with mitotane therapy.
Zuehlke RL
Dermatologica; 1974; 148(2):90-2. PubMed ID: 4276191
[No Abstract] [Full Text] [Related]
20. [Liposomal doxorubicin and palmoplantar erythrodysesthesia].
Tomb R; Stephan F; Halaby G
Ann Dermatol Venereol; 2003 Nov; 130(11):1057-8. PubMed ID: 14724543
[No Abstract] [Full Text] [Related]
[Next] [New Search]
